Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Brittenham

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Hematology/Oncology Clinics of North America|September 1, 1987
Behavioral alterations in iron deficiencyB Lozoff, G M Brittenham
Archives of Pathology & Laboratory Medicine|December 1, 1987
Red blood cell volume distributions and the diagnosis of anemia. Help or hindrance?G M Brittenham, J A Koepke
The Journal of Laboratory and Clinical Medicine|January 1, 1990
Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programsL T Goodnough, G M Brittenham
Annals of the New York Academy of Sciences|July 21, 1998
Long-term trials of deferiprone in Cooley's anemiaN F Olivieri, G M Brittenham
FEBS Letters|August 10, 1992
Bleomycin-reactive iron in patients with acute non-lymphocytic leukemiaV R Gordeuk, G M Brittenham
Blood|February 1, 1997
Iron-chelating therapy and the treatment of thalassemiaN F Olivieri, G M Brittenham
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 10, 1986
Iron overload--still a problem among the Zulus?V R Gordeuk, G M Brittenham
The American Journal of Physiology|April 1, 1987
Statistical and graphical evaluation of erythrocyte volume distributionsC E McLaren, G M Brittenham, V Hasselblad
Blood|March 7, 1998
HBED: A potential alternative to deferoxamine for iron-chelating therapyR J Bergeron, J Wiegand, G M Brittenham
Blood|December 24, 1998
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapyR J Bergeron, J Wiegand, G M Brittenham
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Hematology/Oncology Clinics of North America|September 1, 1987
Behavioral alterations in iron deficiencyB Lozoff, G M Brittenham
Archives of Pathology & Laboratory Medicine|December 1, 1987
Red blood cell volume distributions and the diagnosis of anemia. Help or hindrance?G M Brittenham, J A Koepke
The Journal of Laboratory and Clinical Medicine|January 1, 1990
Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programsL T Goodnough, G M Brittenham
Annals of the New York Academy of Sciences|July 21, 1998
Long-term trials of deferiprone in Cooley's anemiaN F Olivieri, G M Brittenham
FEBS Letters|August 10, 1992
Bleomycin-reactive iron in patients with acute non-lymphocytic leukemiaV R Gordeuk, G M Brittenham
Blood|February 1, 1997
Iron-chelating therapy and the treatment of thalassemiaN F Olivieri, G M Brittenham
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 10, 1986
Iron overload--still a problem among the Zulus?V R Gordeuk, G M Brittenham
The American Journal of Physiology|April 1, 1987
Statistical and graphical evaluation of erythrocyte volume distributionsC E McLaren, G M Brittenham, V Hasselblad
Blood|March 7, 1998
HBED: A potential alternative to deferoxamine for iron-chelating therapyR J Bergeron, J Wiegand, G M Brittenham
Blood|December 24, 1998
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapyR J Bergeron, J Wiegand, G M Brittenham
Pageof 11